Checked against UN INCB controlled substance lists and Japan rules.
Japan allows only CBD products with zero detectable THC. Many foreign CBD products do not meet this standard.
Japan used to decide this by plant part: products made from cannabis stems and seeds were acceptable, products from leaves and flowers were not. That test is gone. Since 12 December 2024 the revised Cannabis Control Act judges the finished product by how much THC is left in it, whatever part of the plant it came from. If a page tells you to check that your CBD is “stem and seed derived,” it was written for a law that no longer applies.
Residual THC limits are set by product form, and they are low:
Oils and fats that are liquid at room temperature, and powders — 10 ppm (0.001%).
Water-soluble solutions — 0.1 ppm (0.00001%).
Everything else — 1 ppm (0.0001%).
A second phase of the same law took effect on 1 March 2025, adding licensing and testing requirements on the supply side.
In the United States and much of Europe, hemp is defined as cannabis containing no more than 0.3% THC, and products are sold lawfully at that ceiling. Convert the units: 0.3% is 3,000 ppm. Japan’s limit for a CBD oil is 10 ppm. A bottle that is entirely legal where you bought it, labelled as hemp and marketed as non-intoxicating, can sit three hundred times above the Japanese threshold and still be exactly what the label says. Nothing about the packaging will tell you this. “THC-free” on a label is a marketing claim, not a measurement against Japan’s standard.
The same revision created a cannabis use offence. Before it, the law reached possession, transfer and cultivation; consumption as such was not separately criminalised. It is now. This matters for travellers because it removes the argument that you only used the product before arriving.
For a CBD product to clear, the documentation travellers are asked for is a certificate of manufacture and a component analysis report from a laboratory showing the THC content. That is a document you have to obtain from the maker before you fly — it is not something you can assemble at the airport, and a screenshot of a product page does not substitute for it.
We could not establish from an official Japanese source how the limits are applied to a small quantity carried for personal use rather than to a commercial import, or whether a traveller is in practice asked for the analysis report at every border. We are not going to fill that gap with a guess. If the product matters to you, ask a Regional Bureau Narcotics Control Department before you book.
Ministry of Health, Labour and Welfare — phased enforcement of the revised Cannabis Control Act
Marunouchi Soleil Law Office — THC residual limit values and the 12 December 2024 date
Tokyo Customs — narcotics, psychotropic drugs and raw materials for stimulants
Associated Kyoto Program — bringing medications into Japan
Last checked 2 October 2026. Where the official pages above disagree with this one, they are right and we are out of date.
Official source for Japan: www.mhlw.go.jp
Original labelled packaging, the prescription, and a letter naming the active ingredient in generic form — control lists are written in generic names, not brands. What the letter must say. And the destination’s own procedure.
Not legal or medical advice. Rules change and depend on dose, form and quantity. Always confirm with the Japan embassy or health authority before you fly. We never tell you a medicine is "safe" to carry.